BCL2 and cancer: In recent years, BH3 mimetics such as ABT-263 and ABT-737, which inhibit activity of pro-survival proteins BCL-2, BCL-XL and BCL-W, have proven to be highly effective at eliminating cancer cells by directly inducing apoptosis [25–27].